相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
Bastien Nguyen et al.
CELL (2022)
Whole-genome and transcriptome analysis enhances precision cancer treatment options
E. Pleasance et al.
ANNALS OF ONCOLOGY (2022)
A comparative analysis of the mutagenicity of platinum-containing chemotherapeutic agents reveals direct and indirect mutagenic mechanisms
Bernadett Szikriszt et al.
MUTAGENESIS (2021)
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
Gonzalo Recondo et al.
CLINICAL CANCER RESEARCH (2020)
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al.
NATURE (2020)
Identification of cancer driver genes based on nucleotide context
Felix Dietlein et al.
NATURE GENETICS (2020)
The landscape of chimeric RNAs in non-diseased tissues and cells
Sandeep Singh et al.
NUCLEIC ACIDS RESEARCH (2020)
Chromosome arm aneuploidies shape tumour evolution and drug response
Ankit Shukla et al.
NATURE COMMUNICATIONS (2020)
Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes
Qingbo Wang et al.
NATURE COMMUNICATIONS (2020)
Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases
Zheng Hu et al.
NATURE GENETICS (2020)
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Aurelien Marabelle et al.
LANCET ONCOLOGY (2020)
Pervasive chromosomal instability and karyotype order in tumour evolution
Thomas B. K. Watkins et al.
NATURE (2020)
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy
Gonzalo Recondo et al.
NPJ PRECISION ONCOLOGY (2020)
Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma
Ji-Feng Feng et al.
JOURNAL OF CANCER (2020)
Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes
Erin Pleasance et al.
NATURE CANCER (2020)
A Compendium of Mutational Signatures of Environmental Agents
Jill E. Kucab et al.
CELL (2019)
Genomic characterization of metastatic breast cancers
Francois Bertucci et al.
NATURE (2019)
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Jordi Rodon et al.
NATURE MEDICINE (2019)
Benchmark and integration of resources for the estimation of human transcription factor activities
Luz Garcia-Alonso et al.
GENOME RESEARCH (2019)
Improved detection of gene fusions by applying statistical methods reveals oncogenic RNA cancer drivers
Roozbeh Dehghannasiri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Pan-cancer whole-genome analyses of metastatic solid tumours
Peter Priestley et al.
NATURE (2019)
The mutational footprints of cancer therapies
Oriol Pich et al.
NATURE GENETICS (2019)
Benchmark of long non-coding RNA quantification for RNA sequencing of cancer samples
Hong Zheng et al.
GIGASCIENCE (2019)
Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods
Brian J. Haas et al.
GENOME BIOLOGY (2019)
TumorFusions: an integrative resource for cancer-associated transcript fusions
Xin Hu et al.
NUCLEIC ACIDS RESEARCH (2018)
ClinVar: improving access to variant interpretations and supporting evidence
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2018)
fastp: an ultra-fast all-in-one FASTQ preprocessor
Shifu Chen et al.
BIOINFORMATICS (2018)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Pathogenic Germline Variants in 10,389 Adult Cancers
Kuan-lin Huang et al.
CELL (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
A clinician friendly data warehouse oriented toward narrative reports: Dr. Warehouse
Nicolas Garcelon et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2018)
Chromosomal instability drives metastasis through a cytosolic DNA response
Samuel F. Bakhoum et al.
NATURE (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
Qingsong Gao et al.
CELL REPORTS (2018)
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
J. Mateo et al.
ANNALS OF ONCOLOGY (2018)
Mosdepth: quick coverage calculation for genomes and exomes
Brent S. Pedersen et al.
BIOINFORMATICS (2018)
Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS
Esko A. Kautto et al.
ONCOTARGET (2017)
Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)
Frederic Bigot et al.
EUROPEAN JOURNAL OF CANCER (2017)
Integrative clinical genomics of metastatic cancer
Dan R. Robinson et al.
NATURE (2017)
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer
Malachi Griffith et al.
NATURE GENETICS (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Origins of lymphatic and distant metastases in human colorectal cancer
Kamila Naxerova et al.
SCIENCE (2017)
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
Christophe Massard et al.
CANCER DISCOVERY (2017)
The association of Phosphatase and tensin homolog (PTEN) deletion and prostate cancer risk: A meta-analysis
Tianyi Gao et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Near-optimal probabilistic RNA-seq quantification
Nicolas L. Bray et al.
NATURE BIOTECHNOLOGY (2016)
Functional characterization of somatic mutations in cancer using network-based inference of protein activity
Mariano J. Alvarez et al.
NATURE GENETICS (2016)
FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing
Ronglai Shen et al.
NUCLEIC ACIDS RESEARCH (2016)
Recurrent chimeric fusion RNAs in non-cancer tissues and cells
Mihaela Babiceanu et al.
NUCLEIC ACIDS RESEARCH (2016)
A comprehensive survey of the mutagenic impact of common cancer cytotoxics
Bernadett Szikriszt et al.
GENOME BIOLOGY (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
The evolutionary history of lethal metastatic prostate cancer
Gunes Gundem et al.
NATURE (2015)
Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention
Song Ling Poon et al.
GENOME MEDICINE (2014)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Discovering chimeric transcripts in paired-end RNA-seq data by using EricScript
Matteo Benelli et al.
BIOINFORMATICS (2012)
Validation of the royal marsden hospital prognostic score in patients treated in the phase I clinical trials program at the MD Anderson Cancer Center
Ignacio Garrido-Laguna et al.
CANCER (2012)
CDKN2A (p16) Promoter Hypermethylation Influences the Outcome in Young Lung Cancer Patients
Dawn P. Bradly et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2012)
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
Nathan T. Ihle et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Cancer classification using the Immunoscore: a worldwide task force
Jerome Galon et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice
Heidemarie Keller et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2012)
Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer
Weiqiang Zhao et al.
JOURNAL OF ONCOLOGY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Prospective Molecular Marker Analyses of EGFR and KRAS From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non-Small-Cell Lung Cancer
Wolfram Brugger et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data
Hajime Uno et al.
STATISTICS IN MEDICINE (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials
Hendrik-Tobias Arkenau et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
M. Yoshimoto et al.
BRITISH JOURNAL OF CANCER (2007)
TICdb:: a collection of gene-mapped translocation breakpoints in cancer
Francisco J. Novo et al.
BMC GENOMICS (2007)
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
M Olivier et al.
CLINICAL CANCER RESEARCH (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)
分享论文
